Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RsqVD in Newly Diagnosed Multiple Myeloma
NCT02219178Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Nov 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Cancer Trials Ireland. Started Nov 2014; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02219178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219178.